U.S. markets open in 47 minutes

Aurora Cannabis Inc. (ACB)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
9.82-0.64 (-6.12%)
At close: 4:00PM EST

9.84 +0.02 (0.20%)
Pre-Market: 8:43AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close10.46
Open10.36
Bid9.44 x 1400
Ask9.50 x 3000
Day's Range9.42 - 10.61
52 Week Range3.71 - 19.68
Volume16,084,738
Avg. Volume25,335,643
Market Cap1.936B
Beta (5Y Monthly)3.11
PE Ratio (TTM)45.46
EPS (TTM)0.22
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Are Any Marijuana Stocks Good Buys Amid March Cooldown?
    Investor's Business Daily

    Are Any Marijuana Stocks Good Buys Amid March Cooldown?

    Marijuana stocks have fallen from their February highs, after greater hopes for U.S. legalization. Does that make any of them good buys now?

  • Canadian premium cannabis company Rubicon Organics initiated as 'strong buy' by Raymond James
    MarketWatch

    Canadian premium cannabis company Rubicon Organics initiated as 'strong buy' by Raymond James

    Raymond James initiated coverage of Canadian cannabis company Rubicon Organics Inc. with a strong buy rating on Thursday, and said the stock is its "very best micro cap cannabis idea." Analyst Rahul Sarugaser assigned the stock a C$6 price target, that's almost double its current level. Rubicon focuses exclusively on super-premium cannabis and is one of only six licensed producers to offer certified organic cannabis products in Canada, the analyst wrote in a note to clients. "Similar to premium liquor brands affiliated with rarity and prestige-Johnny Walker Blue Label is a favorite example-ROMJ is building distinguished premium brands built on a portfolio of intensely high-quality cannabis products designed to generate the sector's highest gross margins: >50%," said the analyst. Rubicon has its roots in Whistler Medical Marijuana Corp., Canada's first organic-certified LP, which was sold to Aurora Cannabis Corp. . Whistler was co-founded by Rubicon's current Chief Executive Jesse McConnell. "ROMJ's expanding team comprises a full complement of seasoned CPG industry executives, leveraging experience from iconic companies and brands such as Coca-Cola, Pepsi, Diageo, L'Oreal, and Nestle," said the note. Raymond James is expecting the company to capture 25% of the premium/craft cannabis market, equal to about 20% of the total market, based on comparable industries such as beer and liquor. That suggests revenue of $26.5 million in 2021 to $52.5 million in 2022. The U.S.-listed stock was not active premarket, but has gained 69% in the last 12 months, while the Cannabis ETF has gained 98% and the S&P) 500 has gained 22%.

  • Yahoo Finance Video

    PREMIUM: Trading profitably and prudently as the world reopens

    With unprecedented monetary and fiscal stimulus as well as a new administration taking shape, trading opportunities are shifting with clearer winners and losers — yet volatility remains. Stephen "Sarge" Guilfoyle, President at Sarge986, joins Yahoo Finance's Jared Blikre to help navigate the emerging post-COVID trading landscape in stocks, bonds, commodities and cryptocurrencies. Focusing on trade selection and setups along with prudent risk management, viewers will also learn how to unlock the power of Yahoo Finance Premium.Not a subscriber? Start your free trial to join future webinars live!